The Impact of dose heterogeneity on late normal tissue complication risk after hypofractionated whole breast radiotherapy
Background and purpose: linear quadratic models predict that hypofractionation increases the biological effect of physical dose inhomogeneity. The clinical significance of this effect was tested retrospectively in a trial of adjuvant breast hypofractionation. Methods: the UK FAST trial randomised 9...
Main Authors: | Tsang, Y.M (Author), Haviland, J.S (Author), Venables, K. (Author), Yarold, JR (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
2012.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Hypofractionated radiotherapy for breast cancer
by: Haviland, J.S, et al.
Published: (2010) -
Hypofractionated whole-breast radiotherapy for women with early breast cancer: myths and realities
by: Yarnold, J., et al.
Published: (2011) -
Large breast size as a risk factor for late adverse effects of breast radiotherapy: is residual dose inhomogeneity, despite 3D treatment planning and on delivery, the main explanation? on behalf of the FAST Trialists' Group.
by: Goldsmith, C., et al.
Published: (2011) -
Hypofractionated whole breast radiotherapy: current perspectives
by: Koulis TA, et al.
Published: (2015-10-01) -
TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early stage breast cancer
by: Andreassen, C.N, et al.
Published: (2005)